Use of atorvastatin in systemic lupus erythematosus in children and adolescentsLaura E. Schanberg, Lisa F. Imundo, Yuki Kimura et al.|Arthritis & Rheumatism|2011Cited by 174
Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive proteinStacy P. Ardoin, Susan D. Thompson, Laura E. Schanberg et al.|Annals of the Rheumatic Diseases|2013Cited by 80
A44: High Levels of DEK Autoantibodies May Predict Early Flare Following Cessation of Anti‐TNF TherapyNirit Mor‐Vaknin, David M. Markovitz, Miguel Rivas et al.|Arthritis & Rheumatology|2014Cited by 1
A20: Understanding the Use and Biology of TNF Therapy in JIA—Clinical OutcomesDaniel J. Lovell, Edward H. Giannini, Anne Johnson et al.|Arthritis & Rheumatology|2014Cited by 1
Understanding the biology and use of TNF therapy in jia-clinical outcomesDaniel J. Lovell, Edward H. Giannini, Anne Johnson et al.|Pediatric Rheumatology|2014Cited by 0